SCHEMBL5834583

SCHEMBL5834583

Nc1ccc2cc3ccccc3cc2c1C=Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RELA Q04206 1/20 0.50
▸ CYP19A1 P11511 2/20 0.42
▸ MAOA P21397 2/20 0.42
▸ MAOB P27338 2/20 0.42
▸ PLG P00747 2/20 0.40
▸ PLAU P00749 2/20 0.40
▸ PLAT P00750 2/20 0.40
▸ KLK1 P06870 2/20 0.40
▸ PPARG P37231 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 3/20 0.39
▸ NFE2L2 Q16236 1/20 0.38
▸ GRM4 Q14833 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP1B1 Q16678 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922074 0.84 CYP1B1 (0.46) RELACYP19A1MAOAMAOBPLG
SCHEMBL56012 0.81 RELA (0.52) RELAPLGPLAUPLATKLK1
SCHEMBL56013 0.81 RELA (0.52) RELAPLGPLAUPLATKLK1
SCHEMBL6422560 0.80 HPRT1 (0.49) RELACYP19A1MAOAMAOBKDM4E
SCHEMBL5750570 0.77 ERN1 (0.42) KDM4EALDH1A1HPGDNPC1LMNA
SCHEMBL129342 0.76 RELA (0.52) RELACYP19A1MAOAMAOBKDM4E
SCHEMBL31589640 0.76 RELA (0.52) RELACYP19A1MAOAMAOBKDM4E
SCHEMBL129341 0.76 RELA (0.52) RELACYP19A1MAOAMAOBKDM4E
(Z)-1,2-Diphenylethene SCHEMBL16161956 0.75 RELA (0.73) RELACYP19A1MAOAMAOBKDM4E
(Z)-1,2-Diphenylethene SCHEMBL16174458 0.75 RELA (0.73) RELACYP19A1MAOAMAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103896825-B A kind of 9,10-diarylethene base anthracene aggregation-induced emission molecule and preparation method thereof SOUTHEAST UNIVERSITY (CN) 2015-11-11 — — CN claimed
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-11-24 — — US claimed
US-6790975-B2 ORGANIC ELECTROLUMINESCENCE; CONDENSATION FROM A CORRESPONDING AMINOBENZALDEHYDE AND A PHOSPHONIC ESTER OR PHOSPHONIUM SALT; YELLOW TO RED LIGHT SONY CORPORATION (JP) 2004-09-14 — — US claimed
US-20030229242-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-12-11 — — US claimed
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-06 — — US claimed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 — — US claimed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 — — EP claimed
CN-103896825-B A kind of 9,10-diarylethene base anthracene aggregation-induced emission molecule and preparation method thereof SOUTHEAST UNIVERSITY (CN) 2015-11-11 — — CN disclosed
CN-103896825-B A kind of 9,10-diarylethene base anthracene aggregation-induced emission molecule and preparation method thereof SOUTHEAST UNIVERSITY (CN) 2015-11-11 — — CN disclosed
CN-103524404-B Pyridine-triphenylamine-anthracene conjugated molecule with aggregation-induced emission property and preparation method thereof UNIV SOUTHEAST 2015-03-18 — — CN disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 — — US disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 — — US disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 — — US disclosed
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-06 — — US disclosed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 — — US disclosed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 — — US disclosed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 — — EP disclosed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 — — EP disclosed
WO-2001077065-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH SONY CORPORATION (JP) 2001-10-18 — — WO disclosed
JP-2001288377-A AMINOSTYRYLANTHRACENE COMPOUND AND INTERMEDIATE FOR SYNTHESIZING THE SAME, AND METHOD FOR PRODUCING THESE COMPOUNDS SONY CORP 2001-10-16 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 RELA 473/4885CYP19A1 217/4885MAOA 1753/4885
US-20030229242-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 RELA 1150/4885CYP19A1 218/4885MAOA 2129/4885
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF AASDHPPT, AADAT, ALDH7A1 RELA 1150/4885CYP19A1 218/4885MAOA 2129/4885
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, ALDH7A1, AGPAT5 RELA 1493/4885CYP19A1 557/4885MAOA 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback